Community Health Systems Inc has a consensus price target of $6.1 based on the ratings of 14 analysts. The high is $12.5 issued by UBS on September 24, 2021. The low is $3 issued by Barclays on March 6, 2024. The 3 most-recent analyst ratings were released by Truist Securities, Truist Securities, and Oppenheimer on July 15, 2024, April 26, 2024, and April 25, 2024, respectively. With an average price target of $4.17 between Truist Securities, Truist Securities, and Oppenheimer, there's an implied 5.49% upside for Community Health Systems Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/15/2024 | Buy Now | 7.59% | Truist Securities | David Macdonald | $3.75 → $4.25 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | -5.06% | Truist Securities | David Macdonald | $3.25 → $3.75 | Maintains | Hold | Get Alert |
04/25/2024 | Buy Now | 13.92% | Oppenheimer | Michael Wiederhorn | $5.5 → $4.5 | Maintains | Outperform | Get Alert |
03/06/2024 | Buy Now | -24.05% | Barclays | Andrew Mok | → $3 | Initiates | → Equal-Weight | Get Alert |
02/22/2024 | Buy Now | 39.24% | Oppenheimer | Michael Wiederhorn | $6.5 → $5.5 | Maintains | Outperform | Get Alert |
10/30/2023 | Buy Now | 51.9% | RBC Capital | Ben Hendrix | $7 → $6 | Maintains | Outperform | Get Alert |
10/20/2023 | Buy Now | -24.05% | Wells Fargo | Stephen Baxter | $5 → $3 | Maintains | Equal-Weight | Get Alert |
10/11/2023 | Buy Now | -11.39% | Truist Securities | David Macdonald | $5 → $3.5 | Maintains | Hold | Get Alert |
08/07/2023 | Buy Now | 64.56% | Oppenheimer | Michael Wiederhorn | → $6.5 | Reiterates | Outperform → Outperform | Get Alert |
06/20/2023 | Buy Now | 26.58% | Truist Securities | David Macdonald | $4.5 → $5 | Maintains | Hold | Get Alert |
05/03/2023 | Buy Now | 77.22% | Citigroup | Jason Cassorla | $9 → $7 | Maintains | Buy | Get Alert |
05/03/2023 | Buy Now | 77.22% | RBC Capital | Ben Hendrix | $11 → $7 | Maintains | Outperform | Get Alert |
05/03/2023 | Buy Now | 26.58% | Wells Fargo | Stephen Baxter | $8 → $5 | Maintains | Equal-Weight | Get Alert |
05/03/2023 | Buy Now | 87.34% | Credit Suisse | Jonathan Yon | $8.5 → $7.4 | Maintains | Neutral | Get Alert |
05/02/2023 | Buy Now | 64.56% | Oppenheimer | Michael Wiederhorn | → $6.5 | Reiterates | → Outperform | Get Alert |
02/17/2023 | Buy Now | 115.19% | Credit Suisse | Jonathan Yong | $3.3 → $8.5 | Maintains | Neutral | Get Alert |
01/19/2023 | Buy Now | 39.24% | Oppenheimer | Colin Rusch | $5 → $5.5 | Maintains | Outperform | Get Alert |
01/03/2023 | Buy Now | 13.92% | Wells Fargo | Stephen Baxter | $3 → $4.5 | Maintains | Equal-Weight | Get Alert |
11/23/2022 | Buy Now | -16.46% | Credit Suisse | A.J. Rice | $4 → $3.3 | Maintains | Neutral | Get Alert |
08/01/2022 | Buy Now | 64.56% | Credit Suisse | A.J. Rice | $8 → $6.5 | Maintains | Neutral | Get Alert |
07/29/2022 | Buy Now | 51.9% | Oppenheimer | Michael Wiederhorn | $16 → $6 | Maintains | Outperform | Get Alert |
06/17/2022 | Buy Now | 26.58% | Loop Capital | Joseph France | → $5 | Initiates | → Hold | Get Alert |
06/15/2022 | Buy Now | 39.24% | B of A Securities | Kevin Fischbeck | $7.5 → $5.5 | Downgrade | Buy → Neutral | Get Alert |
05/02/2022 | Buy Now | 115.19% | Wells Fargo | Stephen Baxter | $12 → $8.5 | Maintains | Equal-Weight | Get Alert |
04/29/2022 | Buy Now | 254.43% | Citigroup | Jason Cassorla | $18 → $14 | Maintains | Buy | Get Alert |
04/29/2022 | Buy Now | 381.01% | RBC Capital | Ben Hendrix | $21 → $19 | Maintains | Outperform | Get Alert |
03/29/2022 | Buy Now | 203.8% | Wells Fargo | Stephen Baxter | → $12 | Initiates | → Equal-Weight | Get Alert |
12/13/2021 | Buy Now | 305.06% | B of A Securities | Kevin Fischbeck | — | Upgrade | Underperform → Buy | Get Alert |
10/29/2021 | Buy Now | 267.09% | Credit Suisse | Jonathan Yong | — | Maintains | Neutral | Get Alert |
09/24/2021 | Buy Now | 216.46% | UBS | — | — | Initiates | → Neutral | Get Alert |
08/03/2021 | Buy Now | 153.16% | Barclays | Steve Valiquette | — | Maintains | Underweight | Get Alert |
07/30/2021 | Buy Now | 203.8% | Credit Suisse | A.J. Rice | — | Maintains | Neutral | Get Alert |
The latest price target for Community Health Sys (NYSE:CYH) was reported by Truist Securities on July 15, 2024. The analyst firm set a price target for $4.25 expecting CYH to rise to within 12 months (a possible 7.59% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Community Health Sys (NYSE:CYH) was provided by Truist Securities, and Community Health Sys maintained their hold rating.
The last upgrade for Community Health Systems Inc happened on December 13, 2021 when B of A Securities raised their price target to $16. B of A Securities previously had an underperform for Community Health Systems Inc.
The last downgrade for Community Health Systems Inc happened on June 15, 2022 when B of A Securities changed their price target from $7.5 to $5.5 for Community Health Systems Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Health Sys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Health Sys was filed on July 15, 2024 so you should expect the next rating to be made available sometime around July 15, 2025.
While ratings are subjective and will change, the latest Community Health Sys (CYH) rating was a maintained with a price target of $3.75 to $4.25. The current price Community Health Sys (CYH) is trading at is $3.95, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.